BlackRock
AZN icon

BlackRock’s AstraZeneca AZN Stock Holding History

BlackRock’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-419,000
Closed -$56.8M – 5281
2024
Q1 		$56.8M Buy
+419,000
New +$55.5M ﹤0.01% 2367
2023
Q1 		– Sell
-171,000
Closed -$23.2M – 5576
2022
Q4 		$23.2M Buy
+171,000
New +$21.4M ﹤0.01% 2945

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

BlackRock's AZN Position: Q1 2026 in Review

BlackRock reduced its AstraZeneca (AZN) stake by 27% in Q1 2026, selling an estimated $159M and leaving 2,232,189 shares worth $440M. The position accounts for 0.01% of the portfolio, ranked #1208.

BlackRock first reported a position in AZN in Q2 2014 and has held it in 46 quarters since. The position peaked at $821M in Q4 2022. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • BlackRock held 2,232,189 shares of AstraZeneca worth $440M as of Q1 2026.
  • BlackRock sold 824,330 AstraZeneca shares in Q1 2026, an estimated $159M.
  • AstraZeneca made up 0.01% of BlackRock's portfolio in Q1 2026, its #1208 holding.
  • BlackRock first reported a position in AstraZeneca in Q2 2014 and has held it in 46 quarters since.
  • BlackRock's AstraZeneca position peaked at $821M in Q4 2022.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.